EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians

Nanna Mørk iD, Julie A Jensen iD, Paul Bastard iD, Lisbeth Aagaard Larsen iD, Bettina Bundgaard iD, Marianne Nygaard iD, Signe Bedsted Clemmensen iD, Chiaki Tao iD, Vibeke Sorensen Catts iD, Anne Puel iD, Guillaume Vogt iD, Ivan David Lozada-Martinez iD und 8 weitere

Journal of Human Immunity · 04.01.2027 · 3 (1)

DOI: 10.70962/jhi.20260143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 27.10.2026. Verfasst von Nanna Mørk und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Aarhus University, Aarhus, Denmark. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, ANRS, NCATS NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While autoantibodies (auto-Abs) neutralizing type I interferons (IFN-I) are relatively rare before the age of 65 (<1%), their prevalence reaches 2–3% between 70 and 80 years and >6% in individuals above 80 years in the general population. To assess the prevalence of IFN-I auto-Abs at the extreme end of human lifespan, we performed a multinational study of centenarians from four geographically and ethnically distinct cohorts collected in Denmark (n = 258), Colombia (n = 99), Australia (n = 281), and Japan (n = 300), comprising 938 individuals. Across cohorts, 51/938 centenarians (5.4%) harbored auto-Abs neutralizing IFN-I, ranging from 3.3% (Japan) to 9.1% (Colombia). We found that the prevalence of IFN-I auto-Abs levels off in centenarians compared with individuals ≥80 years from the general population, demonstrating that neutralizing IFN-I auto-Abs are not incompatible with longevity, despite conferring a risk of life-threatening viral infections. Yet, the plateau of their prevalence in centenarians suggests that they may not be beneficial for reaching exceptional longevity and may negatively impact mortality.

Autor:innen und Institutionen

  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Center for Immunology of Viral Infections, Aarhus University , Aarhus, Denmark.
  • Laboratory of Human Genetics of Infectious Diseases, Institut Imagine, Université Paris Cité, Necker Branch, INSERM UMR 1163, Paris, France.
  • Paris City University, Imagine Institute , Paris, France.
  • Pediatric Hematology-Immunology & Rheumatology Unit, Necker Hospital for Children, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Department of Public Health, Danish Aging Research Center, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Nanna Mørk, Julie A Jensen, Paul Bastard, Lisbeth Aagaard Larsen, Bettina Bundgaard, Marianne Nygaard, Signe Bedsted Clemmensen, Chiaki Tao, Vibeke Sorensen Catts, Anne Puel, Guillaume Vogt, Ivan David Lozada-Martinez, Juan-Manuel Anaya, Yasumichi Arai, Sachdev Singh Perminder, Satoshi Okada, Jean-Laurent Casanova, Kaare Christensen, Aurélie Cobat, Trine H Mogensen

Förderung

  • Japan Agency for Medical Research and Development
  • ANRS
  • NCATS NIH HHS
  • Aarhus University
  • Japan Society for the Promotion of Science
  • French National Research Agency
  • Imagine Institute
  • French Ministry of Higher Education, Research, and Innovation

Zitieren

APA

Mørk, N., Jensen, J. A., Bastard, P., Larsen, L. A., Bundgaard, B., Nygaard, M., Clemmensen, S. B., Tao, C., Catts, V. S., Puel, A., Vogt, G., Lozada-Martinez, I. D., Anaya, J. M., Arai, Y., Perminder, S. S., Okada, S., Casanova, J. L., Christensen, K., Cobat, A., & Mogensen, T. H. (2027). The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians. Journal of Human Immunity, 3(1). https://doi.org/10.70962/jhi.20260143

Vancouver

Mørk N, Jensen JA, Bastard P, Larsen LA, Bundgaard B, Nygaard M, et al. The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians. Journal of Human Immunity. 2027;3(1). doi:10.70962/jhi.20260143

BibTeX
@article{Mrk2027,
  author = {Mørk, Nanna and Jensen, Julie A and Bastard, Paul and Larsen, Lisbeth Aagaard and Bundgaard, Bettina and Nygaard, Marianne and Clemmensen, Signe Bedsted and Tao, Chiaki and Catts, Vibeke Sorensen and Puel, Anne and Vogt, Guillaume and Lozada-Martinez, Ivan David and Anaya, Juan-Manuel and Arai, Yasumichi and Perminder, Sachdev Singh and Okada, Satoshi and Casanova, Jean-Laurent and Christensen, Kaare and Cobat, Aurélie and Mogensen, Trine H},
  title = {The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians},
  journal = {Journal of Human Immunity},
  year = {2027},
  volume = {3},
  number = {1},
  doi = {10.70962/jhi.20260143}
}
Kostenlos starten →